ATE226949T1 - Verfahren zur herstellung von tolterodin - Google Patents
Verfahren zur herstellung von tolterodinInfo
- Publication number
- ATE226949T1 ATE226949T1 AT97954678T AT97954678T ATE226949T1 AT E226949 T1 ATE226949 T1 AT E226949T1 AT 97954678 T AT97954678 T AT 97954678T AT 97954678 T AT97954678 T AT 97954678T AT E226949 T1 ATE226949 T1 AT E226949T1
- Authority
- AT
- Austria
- Prior art keywords
- tolterodine
- producing
- producing tolterodine
- benzopyran
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Pyrane Compounds (AREA)
- Optical Integrated Circuits (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3396196P | 1996-12-31 | 1996-12-31 | |
| PCT/US1997/022521 WO1998029402A1 (en) | 1996-12-31 | 1997-12-18 | Process to prepare tolterodine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE226949T1 true ATE226949T1 (de) | 2002-11-15 |
Family
ID=21873473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97954678T ATE226949T1 (de) | 1996-12-31 | 1997-12-18 | Verfahren zur herstellung von tolterodin |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5922914A (de) |
| EP (1) | EP0960109B1 (de) |
| JP (1) | JP4199310B2 (de) |
| KR (2) | KR20000057548A (de) |
| CN (1) | CN1151141C (de) |
| AT (1) | ATE226949T1 (de) |
| AU (1) | AU717985B2 (de) |
| CA (1) | CA2273789C (de) |
| CZ (1) | CZ295477B6 (de) |
| DE (1) | DE69716767T2 (de) |
| DK (1) | DK0960109T3 (de) |
| ES (1) | ES2186018T3 (de) |
| FI (1) | FI991477A7 (de) |
| HU (1) | HUP0000527A3 (de) |
| NO (1) | NO317158B1 (de) |
| NZ (1) | NZ336533A (de) |
| PL (1) | PL191603B1 (de) |
| PT (1) | PT960109E (de) |
| RU (1) | RU2176246C2 (de) |
| SI (1) | SI0960109T1 (de) |
| SK (1) | SK283591B6 (de) |
| WO (1) | WO1998029402A1 (de) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000515525A (ja) * | 1996-07-19 | 2000-11-21 | アベーグ，グンナー | 尿と胃腸の疾患の治療におけるｓ（―）―トルテロジン |
| EP0957073A1 (de) * | 1998-05-12 | 1999-11-17 | Schwarz Pharma Ag | 3,3-Diphenylpropylaminderivate |
| DE60035232T2 (de) * | 1999-07-01 | 2008-02-14 | Pharmacia & Upjohn Co. Llc, Kalamazoo | (S,S)-Reboxetin zur Behandlung von chronischem Müdigkeits-Syndrom |
| SE9904850D0 (sv) * | 1999-12-30 | 1999-12-30 | Pharmacia & Upjohn Ab | Novel process and intermediates |
| US6566537B2 (en) | 1999-12-30 | 2003-05-20 | Pharmacia Ab | Process and intermediates |
| DE10028443C1 (de) * | 2000-06-14 | 2002-05-29 | Sanol Arznei Schwarz Gmbh | Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen |
| DE10033016A1 (de) | 2000-07-07 | 2002-01-24 | Sanol Arznei Schwarz Gmbh | Verfahren zur Herstellung von 3,3-Diarylpropylaminen |
| PE20020547A1 (es) | 2000-10-24 | 2002-06-12 | Upjohn Co | Uso de la tolterodina en tratamientos del asma |
| US20030027856A1 (en) * | 2001-06-29 | 2003-02-06 | Aberg A.K. Gunnar | Tolterodine metabolites |
| IN191835B (de) * | 2001-08-03 | 2004-01-10 | Ranbaxy Lab Ltd | |
| EP1461306B1 (de) | 2001-10-26 | 2008-12-24 | Pharmacia & Upjohn Company LLC | Quaternäre ammoniumverbindungen und deren verwendung als antimuscarinische wirkstoffe |
| US7005449B2 (en) | 2002-04-23 | 2006-02-28 | Pharmacia & Upjohn Company | Tolterodine salts |
| DE60230683D1 (de) | 2002-07-08 | 2009-02-12 | Ranbaxy Lab Ltd | 3,6-disubstituierte azabicyclo-3.1.0 hexan-derivat |
| DE60226906D1 (de) | 2002-07-31 | 2008-07-10 | Ranbaxy Lab Ltd | 3,6-disubstituierte azabicyclo ä3.1.0ühexanderivate, die sich als muscarinrezeptorantagonisten eignen |
| AU2002321711A1 (en) | 2002-08-09 | 2004-02-25 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives useful as muscarinic receptor antagonist |
| WO2004018422A1 (en) | 2002-08-23 | 2004-03-04 | Ranbaxy Laboratories Limited | Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists |
| EP1536780A1 (de) * | 2002-08-28 | 2005-06-08 | Pharmacia Corporation | Orale fl ssige tolterodin-zusammensetzung |
| DE60227576D1 (de) | 2002-12-10 | 2008-08-21 | Ranbaxy Lab Ltd | 3,6-DISUBSTITUIERTE AZABICYCLO i3.1.0 -HEXANDERIVATIVE ALS ANTAGONISTEN DES MUSCARINREZEPTORS |
| AU2002347553A1 (en) | 2002-12-23 | 2004-07-14 | Ranbaxy Laboratories Limited | Flavaxate derivatives as muscarinic receptor antagonists |
| EP1583741A1 (de) | 2002-12-23 | 2005-10-12 | Ranbaxy Laboratories, Limited | 1-substituierte-3-pyrrolidin-derivate als muscarinrezeptor-antagonisten |
| US7488748B2 (en) | 2003-01-28 | 2009-02-10 | Ranbaxy Laboratories Limited | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| EP1603862A1 (de) * | 2003-03-06 | 2005-12-14 | Ranbaxy Laboratories Limited | 3,3-diarylpropylaminderivate und verfahren zu deren isolierung |
| DE10315917A1 (de) * | 2003-04-08 | 2004-11-18 | Schwarz Pharma Ag | Hochreine Basen von 3,3-Diphenylpropylaminmonoestern |
| AU2003304037A1 (en) * | 2003-04-08 | 2004-11-01 | Hetero Drugs Limited | Novel polymorphs of tolterodine tartrate |
| US7517905B2 (en) | 2003-04-09 | 2009-04-14 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| US7560479B2 (en) | 2003-04-10 | 2009-07-14 | Ranbaxy Laboratories Limited | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| JP2006514978A (ja) | 2003-04-10 | 2006-05-18 | ランバクシー ラボラトリーズ リミテッド | ムスカリン受容体アンタゴニストである置換アザビシクロヘキサン誘導体 |
| CA2522071A1 (en) | 2003-04-11 | 2004-10-21 | Ranbaxy Laboratories Limited | Azabicyclo derivatives as muscarinic receptor antagonists |
| ITMI20031354A1 (it) * | 2003-07-02 | 2005-01-03 | Istituto Di Chimica Biomolecolare D El Cnr Sezione | Sintesis enantioselettiva di composti enantiomericamente arricchiti. |
| ES2235648B1 (es) * | 2003-12-22 | 2006-11-01 | Ragactives, S.L. | Procedimiento para la obtencion de tolterodina. |
| US7538249B2 (en) * | 2003-12-24 | 2009-05-26 | Cipla Limited | Tolterodine, compositions and uses thereof, and preparation of the same |
| EP1629834A1 (de) | 2004-08-27 | 2006-03-01 | KRKA, D.D., Novo Mesto | Pharmazeutische Zusammensetzung von Tolterodin mit verzögerter Freisetzung |
| ITMI20041920A1 (it) * | 2004-10-11 | 2005-01-11 | Chemi Spa | Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina |
| US7355077B2 (en) * | 2004-10-28 | 2008-04-08 | Dr. Reddy's Laboratories Limited | Process for preparing tolterodine |
| JP4513535B2 (ja) * | 2004-12-03 | 2010-07-28 | 住友化学株式会社 | トルテロジンの製造方法 |
| WO2006074479A1 (en) * | 2005-01-10 | 2006-07-13 | Teva Pharmaceutical Industries, Ltd. | Process for preparing tolterodine tartrate |
| US7528267B2 (en) | 2005-08-01 | 2009-05-05 | Girindus America, Inc. | Method for enantioselective hydrogenation of chromenes |
| ES2268987B1 (es) * | 2005-08-05 | 2008-02-01 | Ragactives, S.L. | Procedimiento para la obtencion de 3,3-difenilpropilaminas. |
| WO2007039918A1 (en) * | 2005-10-06 | 2007-04-12 | Natco Pharma Limited | Novel process for the preparation of tolterodine |
| RU2008119323A (ru) | 2005-10-19 | 2009-11-27 | Рэнбакси Лабораториз Лимитед (In) | Фармацевтические композиции мускаринового рецептора |
| KR100686351B1 (ko) * | 2006-01-12 | 2007-02-22 | 주식회사 카이로제닉스 | 톨테로딘 라세미체의 제조방법 |
| ITMI20060110A1 (it) * | 2006-01-24 | 2007-07-25 | Dipharma Spa | Procedimento per la purificazione di tolterodina |
| KR101087326B1 (ko) | 2006-05-24 | 2011-11-25 | 화이자 리미티드 | 벤조피란-２-올 유도체의 생성 방법 |
| US7268257B1 (en) | 2006-05-31 | 2007-09-11 | Sumitomo Chemical Company, Limited | Process for producing tolterodine |
| CZ302585B6 (cs) * | 2007-02-26 | 2011-07-20 | Zentiva, A. S. | Krystalická sul 2-[(1R)-3-[bis(1-methylethyl)amino]-1-fenylpropyl]-4-methylfenolu s kyselinou (2R,3R)-2,3-dihydroxybutandiovou |
| US8486452B2 (en) * | 2007-07-20 | 2013-07-16 | Mylan Pharmaceuticals Inc. | Stabilized tolterodine tartrate formulations |
| WO2009019599A2 (en) | 2007-08-08 | 2009-02-12 | Themis Laboratories Private Limited | Extended release compositions comprising tolterodine |
| KR101188333B1 (ko) * | 2008-02-20 | 2012-10-09 | 에스케이케미칼주식회사 | 안정성이 우수하고 경피제로 유용한 톨테로딘 결정성산부가염 |
| US20090214665A1 (en) * | 2008-02-26 | 2009-08-27 | Lai Felix S | Controlled Release Muscarinic Receptor Antagonist Formulation |
| ITMI20082055A1 (it) * | 2008-11-19 | 2009-02-18 | Dipharma Francis Srl | Procedimento per la preparazione di (r)-tolterodina base libera |
| WO2010092500A2 (en) | 2009-02-12 | 2010-08-19 | Alembic Limited | A process for the preparation of tolterodine tartrate |
| US20120041235A1 (en) * | 2009-02-17 | 2012-02-16 | Pharmathen S.A. | Process for the preparation of (r)-2-(3-diisopropylamino)-1-phenylpropyl)-4methylphenol and salts thereof |
| ES2604705T3 (es) | 2010-03-31 | 2017-03-08 | Ono Pharmaceutical Co., Ltd. | Agente preventivo y/o remedio para el síndrome mano-pie |
| WO2012098044A1 (en) | 2011-01-17 | 2012-07-26 | Cambrex Profarmaco Milano S.R.L. | Process for the preparation of n,n-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl propylamine and its salts starting from a novel intermediate |
| EP2476665A1 (de) | 2011-01-17 | 2012-07-18 | Cambrex Profarmaco Milano S.r.l. | Verfahren zur Herstellung von N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl-Propylamin und seine Salze aus einem neuartigen Zwischenstoffs |
| CN102516098B (zh) * | 2011-12-09 | 2014-06-18 | 北京联本医药化学技术有限公司 | 酒石酸托特罗定制备方法 |
| CN103044274B (zh) * | 2012-11-29 | 2014-10-22 | 珠海保税区丽珠合成制药有限公司 | 一种无溶剂合成酒石酸托特罗定的方法 |
| GB201402556D0 (en) | 2014-02-13 | 2014-04-02 | Crystec Ltd | Improvements relating to inhalable particles |
| CN110229072B (zh) * | 2019-06-25 | 2022-04-08 | 中国药科大学 | 一种托特罗定及其对映体的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1169945A (en) * | 1966-08-25 | 1969-11-05 | Geistlich Soehne Ag | Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives |
| SE8800207D0 (sv) * | 1988-01-22 | 1988-01-22 | Kabivitrum Ab | Nya aminer, deras anvendning och framstellning |
| US5382600A (en) * | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
| ATE161530T1 (de) * | 1992-09-04 | 1998-01-15 | Takeda Chemical Industries Ltd | Kondensierte heterozyklische verbindungen, deren herstellung und verwendung |
| RU2089539C1 (ru) * | 1994-04-05 | 1997-09-10 | Стерлитамакский нефтехимических завод | Способ получения 2,5-n,n'-(диметиламинометил)-1,4-гидрохинона |
-
1997
- 1997-11-21 KR KR1019990705269A patent/KR20000057548A/ko not_active Withdrawn
- 1997-12-18 RU RU99116356/04A patent/RU2176246C2/ru not_active IP Right Cessation
- 1997-12-18 CN CNB971801479A patent/CN1151141C/zh not_active Expired - Fee Related
- 1997-12-18 DE DE69716767T patent/DE69716767T2/de not_active Expired - Lifetime
- 1997-12-18 NZ NZ336533A patent/NZ336533A/xx not_active IP Right Cessation
- 1997-12-18 DK DK97954678T patent/DK0960109T3/da active
- 1997-12-18 CA CA002273789A patent/CA2273789C/en not_active Expired - Fee Related
- 1997-12-18 US US08/993,257 patent/US5922914A/en not_active Expired - Lifetime
- 1997-12-18 AU AU59569/98A patent/AU717985B2/en not_active Ceased
- 1997-12-18 KR KR10-1999-7005910A patent/KR100463614B1/ko not_active Expired - Fee Related
- 1997-12-18 EP EP97954678A patent/EP0960109B1/de not_active Expired - Lifetime
- 1997-12-18 CZ CZ19992272A patent/CZ295477B6/cs not_active IP Right Cessation
- 1997-12-18 WO PCT/US1997/022521 patent/WO1998029402A1/en not_active Ceased
- 1997-12-18 AT AT97954678T patent/ATE226949T1/de active
- 1997-12-18 PT PT97954678T patent/PT960109E/pt unknown
- 1997-12-18 HU HU0000527A patent/HUP0000527A3/hu unknown
- 1997-12-18 SK SK815-99A patent/SK283591B6/sk not_active IP Right Cessation
- 1997-12-18 FI FI991477A patent/FI991477A7/fi unknown
- 1997-12-18 JP JP53003098A patent/JP4199310B2/ja not_active Expired - Fee Related
- 1997-12-18 ES ES97954678T patent/ES2186018T3/es not_active Expired - Lifetime
- 1997-12-18 PL PL334375A patent/PL191603B1/pl not_active IP Right Cessation
- 1997-12-18 SI SI9730426T patent/SI0960109T1/xx unknown
-
1999
- 1999-06-29 NO NO19993247A patent/NO317158B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE226949T1 (de) | Verfahren zur herstellung von tolterodin | |
| DE69620461D1 (de) | Verfahren zur herstellung von 1,1,1,3,3,-pentafluoropropanen | |
| DE69623460D1 (de) | Verfahren zur herstellung von 3-haloalkyl-1h-pyrazole | |
| ATE326476T1 (de) | Verfahren zur herstellung von phosphorothioat- oligomeren | |
| ATE241012T1 (de) | Verfahren zur herstellung von humanen relaxin | |
| DE59001438D1 (de) | Verfahren zur herstellung von tetrabrom-4,4'-alkyliden-diphenolen. | |
| DE59007171D1 (de) | Verfahren zur herstellung von sclareolid. | |
| DE3771657D1 (de) | Verfahren zur herstellung von cyclopentanon. | |
| DE69425496D1 (de) | Verfahren zur herstellung von 1,4-dienen | |
| DE3787543D1 (de) | Verfahren zur herstellung von 6,13-dihydrochinacridonen und chinacridonen. | |
| DE3888523D1 (de) | Verfahren zur herstellung von 4,4'-dibromdiphenylether. | |
| ATA41091A (de) | Verfahren zur herstellung von beta-(d)-2',3'-didesoxyinosin | |
| DE59001106D1 (de) | Verfahren zur herstellung von 1,1,1-trifluor-2-chlorethan. | |
| ATE182143T1 (de) | Verfahren zur herstellung von 1,2- benzisothiazolonen | |
| ATE187959T1 (de) | Lösungsmittelfreies verfahren zur herstellung von 2,6 difluorbenzonitril | |
| DE59510636D1 (de) | Verfahren zur herstellung von 8-alpha,12-oxido-13,14,15,16-tetranorlabdan | |
| DE3779247D1 (de) | Verfahren zur herstellung von 2,3,5-trimethylhydrochinon. | |
| DE58904175D1 (de) | Verfahren zur herstellung von 4,4'-dihalogeno-biphenylen. | |
| DE68916022D1 (de) | Verfahren zur herstellung von wasserstoffgas. | |
| DE69002134D1 (de) | Verfahren zur herstellung von 1,1-dichlor-1-fluoroethan und 1-chlor-1-1-difluorethan. | |
| ATE211716T1 (de) | Verfahren zur herstellung von feinverteiltes metallisches kobalt enthaltendem kobalt(ii)-oxid | |
| DE3770059D1 (de) | Verfahren zur herstellung von 4,4'-bis-phenol. | |
| ATE269863T1 (de) | Verfahren zur herstellung von granisetron | |
| DE69418723D1 (de) | Verfahren zur herstellung von 1,1,2,3,3-pentafluorpropan | |
| DE69012103D1 (de) | Verfahren zur herstellung von 4,4'-diisopropylbiphenyl. |